Juraj Konc is a postdoctoral researcher at St. Anna Children's Cancer Research Institute (CCRI) and CeMM, focusing on immune deficiency, cancer predisposition, and precision oncology under the guidance of Prof. Kaan Boztug. Juraj Konc has developed novel immunotherapeutic strategies for high-risk neuroblastoma. Prior to this, Juraj Konc completed a PhD in Chemistry at the University of Cambridge, working in the biological chemistry research group of Prof. Gonçalo Bernardes, where protocols for chemical modification of antibodies and DNA were developed, alongside bioorthogonal chemistry approaches for prodrug activation therapy. Educational background includes a Master's degree in Organic Chemistry and a Bachelor's degree in Clinical and Toxicological Analysis from Charles University. Juraj Konc has also held a laboratory technician position at IOCB Prague, where the synthesis of sugar-modified ribonucleoside derivatives for biological activity screening was conducted.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).